{"database": "lobbying", "table": "lobbying_activities", "rows": [[1004604, "f1a4e68d-f766-4df9-adac-38402db65ee4", "Q3", "AMERICAN PHARMACISTS ASSOCIATION", 3071, "AMERICAN PHARMACISTS ASSOCIATION", 2010, "third_quarter", "PHA", "HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010\nS 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009\nS 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 \nS 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009\nHAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program\nHR 1204 - The Community Pharmacy Fairness Act of 2009\nS 754 - The Methadone Treatment and Protection Act of 2009 \nHR 2855 - The Drug Overdose Reduction Act\nHR 163 - Prescription Drug Affordability Act\nHR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps\n\n(Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes\n(Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory\nCommittee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS\n(Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments\n(Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings\n(Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period\n(Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing\n(Docket Number: DEA  337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information\n(Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies\n\nDEA National Drug Take-Back Day \n\nConcept  Standardizing REMS programs, components and development of a potential tiered REMS System", "Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", null, 212859, 0, 0, "2010-10-19T14:57:56.533000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1004604"], "units": {}, "query_ms": 3.871958004310727, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}